Assessing returns from recommended medication use by US Medicare beneficiaries with diabetes

被引：0
|
作者：
Stuart, Bruce
Simom-Wastila, Linda
Zhao, Lirong
Doshi, Jalpa
机构：
[1] Univ Maryland, Peter Lamy Ctr Drug Therapy & Aging, Baltimore, MD 21201 USA
[2] Univ Philadelphia, Philadelphia, PA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
269
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] DETERMINANTS OF PERSISTENT MEDICATION USE AMONG MEDICARE BENEFICIARIES WITH DIABETES
    Lloyd, J.
    Stuart, B.
    Shoemaker, J.
    Shaffer, T.
    GERONTOLOGIST, 2009, 49 : 268 - 268
  • [2] The treatment risk parodox in medication use by Medicare beneficiaries with diabetes
    Stuart, B
    Limcangco, R
    GERONTOLOGIST, 2005, 45 : 621 - 621
  • [3] Increased Persistency in Medication Use by US Medicare Beneficiaries With Diabetes Is Associated With Lower Hospitalization Rates and Cost Savings
    Stuart, Bruce C.
    Simoni-Wastila, Linda
    Zhao, Lirong
    Lloyd, Jennifer T.
    Doshi, Jalpa A.
    DIABETES CARE, 2009, 32 (04) : 647 - 649
  • [4] Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus
    Tjia, Jennifer
    Briesacher, Becky A.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (10) : 1879 - 1886
  • [5] Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries
    Gu, Dian
    Shen, Chan
    DRUGS & AGING, 2019, 36 (12) : 1111 - 1121
  • [6] Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries
    Dian Gu
    Chan Shen
    Drugs & Aging, 2019, 36 : 1111 - 1121
  • [7] Racial Disparities in Cost of Diabetes for US Medicare Beneficiaries
    Glantz, Namino M.
    Duncan, Ian
    Ahmed, Tamim
    Fan, Ludi
    Reed, Beverly
    Kalirai, Samaneh
    Kerr, David
    DIABETES, 2018, 67
  • [8] Differences in Diabetes Medication Use between Commercial and Medicare Advantage Beneficiaries, 2013-2018
    McCoy, Rozalina G.
    Van Houten, Holly
    Ross, Joseph
    Karaca-Mandic, Pinar
    Montori, Victor M.
    Shah, Nilay
    DIABETES, 2020, 69
  • [9] MEDICATION USE BY COMMUNITY DWELLING MEDICARE BENEFICIARIES AT THE END OF LIFE
    Shaffer, T.
    Simoni-Wastila, L.
    Toler, W.
    Stuart, B.
    Doshi, J. A.
    GERONTOLOGIST, 2009, 49 : 136 - 137
  • [10] Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016
    Zhao, Julie Z.
    Weinhandl, Eric D.
    Carlson, Angeline M.
    St Peter, Wendy L.
    KIDNEY MEDICINE, 2021, 3 (02) : 173 - +
12345